NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

India to Launch Nationwide HPV Vaccination Campaign

Key Highlights

  • Government of India will roll out a nationwide Human Papillomavirus (HPV) vaccination campaign to fulfill its promise of "Swastha Nari".
  • The campaign aims to target cervical cancer, a common type of cancer among women in India.
  • Gardasil injection will be administered free of cost to girls aged 14 and above.

Program Details

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

  • The vaccination program will be voluntary and free of cost, ensuring equitable access across socio-economic groups.
  • The quadrivalent HPV vaccine protects against HPV types 16 and 18, which cause cervical cancer, as well as types 6 and 11.
  • The vaccine provides robust and durable protection when administered to girls in the recommended age group, with a single dose providing adequate protection.

Targeted Population

  • Girls aged 14 and above will be provided a free dose of the vaccine under the national campaign.
  • The campaign aims to ensure equitable access to the vaccine, regardless of socio-economic background.

Investor Takeaway

This initiative may have a positive long-term impact on the Indian healthcare sector, particularly for pharma companies involved in HPV vaccine production.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.